Evidence map›Paper›PMID 36497111›Full record

ArticleCells2022

HyClear: A Novel Tissue Clearing Solution for One-Step Clearing of Microtissues.

S Soroush Nasseri, Erika M J Siren, Jayachandran N Kizhakkedathu, Karen Cheung

Open access · goldAbstract read
In one paragraph

Article in Cells, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 62% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

S Soroush NasseriSchool of Biomedical Engineering, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.ORCID 0000-0001-7153-5502
Erika M J SirenCentre for Blood Research, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
Jayachandran N KizhakkedathuSchool of Biomedical Engineering, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.ORCID 0000-0001-7688-7574
Karen CheungSchool of Biomedical Engineering, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
University of British Columbia · CA

Funding

Mitacs IT13602Natural Sciences and Engineering Research Council RGPIN-2015-04324
6 · The paper itself

Abstract

3-D cell cultures are being increasingly used as in vitro models are capable of better mimicry of in vivo tissues, particularly in drug screenings where mass transfer limitations can affect the cancer biology and response to drugs. Three-dimensional microscopy techniques, such as confocal and multiphoton microscopy, have been used to elucidate data from 3-D cell cultures and whole organs, but their reach inside the 3-D tissues is restrained by the light scattering of the tissues, limiting their effective reach to 100-200 µm, which is simply not enough. Tissue clearing protocols, developed mostly for larger specimens usually involve multiple steps of viscous liquid submersion, and are not easily adaptable for much smaller spheroids and organoids. In this work, we have developed a novel tissue clearing solution tailored for small spheroids and organoids. Our tissue clearing protocol, called HyClear, uses a mixture of DMSO, HPG and urea to allow for one-step tissue clearing of spheroids and organoids, and is compatible with high-throughput screening studies due to its speed and simplicity. We have shown that our tissue clearing agent is superior to many of the commonly used tissue clearing agents and allows for elucidating better quality data from drug screening experiments.

Indexed as

MicroscopyOrganoidsHigh-Throughput Screening Assays3-DDMSOHPGmicroscopyorganoidspheroidtissue clearing

Identifiers

PMID36497111
PMCPMC9738288
OpenAlexW4311045421

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.